Efficacy and safety of PD-L1 inhibitor durvalumab in HIV+ patients with advanced solid tumors June 21, 2019
GSK initiates phase III trials of GSK-3196165 in moderate to severely active rheumatoid arthritis June 20, 2019
RSS